Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04450017
What this trial is testing

Clinical Features of Severe Patients With COVID-19

Who this might be right for
SARS-CoV2
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 200
Testing effectiveness (Phase 2)Looking for participantsNCT07406217
What this trial is testing

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

Who this might be right for
COVID-19Immunodeficiency
Calmy Alexandra 256
Not applicableUnknownNCT04799808
What this trial is testing

Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff

Who this might be right for
SARS-CoV-2 InfectionActive ImmunizationImmune Response+1 more
Technische Universität Dresden 3,500
Not applicableStudy completedNCT04366817
What this trial is testing

Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact

Who this might be right for
Post Partum Depression
Assistance Publique - Hôpitaux de Paris 287
Not applicableActive Not RecruitingNCT04393649
What this trial is testing

First Level Socio-geriatric Evaluation: ESOGER Databank

Who this might be right for
COVIDSocial IsolationAnxiety+1 more
Jewish General Hospital 20,000
Not applicableStudy completedNCT04377685
What this trial is testing

Prediction of Clinical Course in COVID19 Patients

Who this might be right for
COVID 19
Centre Hospitalier Universitaire de Saint Etienne 826
Not applicableUnknownNCT05175989
What this trial is testing

SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19

Who this might be right for
COVID-19 Vaccine
Rabin Medical Center 150
Not applicableUnknownNCT04534608
What this trial is testing

COVID-19 Child Health Investigation of Latent Disease in Hamburg

Who this might be right for
SARS-CoV-2Covid19
Universitätsklinikum Hamburg-Eppendorf 6,000
Not applicableStudy completedNCT06668025
What this trial is testing

MxA-Guided Antiviral Treatment in Respiratory Viral Infections

Who this might be right for
Respiratory Viral InfectionsInfluenzaSARS CoV-2
Capital Medical University 86
Not applicableUnknownNCT04446338
What this trial is testing

Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre

Who this might be right for
History of Covid-19, Seroprevalence
University Hospital Tuebingen 300
Not applicableStudy completedNCT04591015
What this trial is testing

Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19

Who this might be right for
Diabetes Mellitus, Type 2Covid19
Scripps Whittier Diabetes Institute 172
Large-scale testing (Phase 3)Study completedNCT04887948
What this trial is testing

Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

Who this might be right for
Pneumococcal DiseaseCOVID-19SARS-CoV-2 Infection
Pfizer 570
Not applicableEnded earlyNCT05084755
What this trial is testing

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19

Who this might be right for
Prevention of Infectious Disease Caused by SARS-CoV-2
AstraZeneca 4
Early research (Phase 1)Ended earlyNCT05027815
What this trial is testing

Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)

Who this might be right for
Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
Jeffrey Bluestone 7
Testing effectiveness (Phase 2)Study completedNCT04425252
What this trial is testing

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

Who this might be right for
COVID-19
Clear Creek Bio, Inc. 25
Not applicableNot Yet RecruitingNCT06610643
What this trial is testing

Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients

Who this might be right for
COVID-19SARS-CoV-2Immunocompromised
National Taiwan University Hospital 40
Not applicableStudy completedNCT04970563
What this trial is testing

Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: "Proof of Concept" Study (CoviDetectionDog)-Covid-19

Who this might be right for
Infection by SARS-COV-2Healthy Controls
Hôpital Européen Marseille 160
Not applicableStudy completedNCT04590794
What this trial is testing

SuPAR in Adult Patients With Covid-19

Who this might be right for
Covid19
University of Thessaly 767
Large-scale testing (Phase 3)UnknownNCT04536051
What this trial is testing

A Candidate COVID-19 Vaccine (COV003)

Who this might be right for
Coronavirus
University of Oxford 10,300
Not applicableStudy completedNCT04703777
What this trial is testing

Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic

Who this might be right for
Covid-19
University Hospital, Strasbourg, France 500
Next Page